A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months

Clinical trial NCT06049927 · COMPLETED

Trial details

NCT number: NCT06049927
Sponsor: Sinovac Biotech Co., Ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Seasonal Influenza

Start date: 2023-09-16
Primary completion: 2024-05-23
Enrollment: 3300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.